DAR2487
Posted - 04/30/24
$GPCR trading higher from Eli lily? Hmm
Justy_Nuff
Posted - 04/30/24
$GPCR what happened????
Quantumup
Posted - 04/23/24
BMO $GPCR OP/$83 Oral GLP-1RAs will be the next leap4ward4metabolic med. A "homerun" (26% wt loss) could renew inv zeal, shrs currently reflect a less conclusive readout (5-6% wt loss), considered fixable w/ optimal dosing; incremental updates, T2D validation make⬇️side unlikely: $vktx $lly $nvo
biolover
Posted - 04/21/24
$ALT $GPCR $LLY $NVO $VKTX all these drugs are known and of no competition to Viking drug. Not the sc nor the po
RonIsWrong
Posted - 04/21/24
13 new obesity drugs could hit the market by 2029 amid surging demand $LLY $NVO [...] Beginning in 2024, the number of obesity drug launches is expected to climb significantly, reaching a peak of four launches per year in 2027 and 2028. [...] Other drug candidates in mid-stage development for obesity include Viking Therapeutics’ ($VKTX) VK2735, Structure Therapeutics’ ($GPCR) GSBR-1290 and Altimmune’s ($ALT) pemvidutide, Pfizer’s (PFE) danuglipron, and Amgen’s (AMGN) AMG133, also known as MariTide.
NoFearHere
Posted - 04/18/24
$GPCR it's back in the buy Zone this line is held it so far
BioRich
Posted - 04/15/24
$TERN Phase 1 Readout for TERN-601 and TERN-701 expected in 2H24. Preliminary information shared in last earnings call/presentation shows extremely optimistic outcomes. Strong balance sheet with cash on hand to fund through 2025. Added a new CBO (Chief Business Officer) that led $GPCR Structure Therapeutics to a success IPO and served as Senior VP and Head of Business Development for monster $SGMO where she secured licensing agreements with major market players with the potential value in excess of 6$ billion. The presentation slides show how initial data compares to $ALT and $VKTX and was insanely impressive. I'll post when I find. Not a pump, I believe this is a lottery ticket at these prices and it's potential.
RickiWins
Posted - 04/10/24
$TERN $GPCR was her former company, peep the value
BullYa
Posted - 04/09/24
$GPCR ridiculous! Buy the dip with $3.40 discount per share, that’s a good deal of the day.
Justy_Nuff
Posted - 04/05/24
$GPCR gpcr let's gooooo
CDMO
Posted - 04/02/24
$GPCR got stopped out today, 4% loss
OMillionaires
Posted - 03/25/24
lets go $GPCR back over $45 plz
Rkramden60
Posted - 03/22/24
$GPCR I own a ton of this but you take a close look at $LENZ looks very promising!! My two cents
Stayfocused489
Posted - 03/21/24
$GPCR Even with help they are a long shot. $VKTX as well another long shot.
Stayfocused489
Posted - 03/21/24
$GPCR Doesn’t this do the same As the other ones? GLP-1 Inhibitor being the main source. Who would take this on. Phizer? Doing DD.
Stayfocused489
Posted - 03/21/24
$GPCR Bullish on a temporary pull back.
ExcelsiorTrading
Posted - 03/21/24
$GPCR what a beast
Rkramden60
Posted - 03/21/24
$GPCR does anyone think a partnership or buyout is possible soon!!!
OMillionaires
Posted - 03/21/24
3rd time a charm at $50 for $GPCR ?
OMillionaires
Posted - 03/21/24
In more $GPCR calls
NoFearHere
Posted - 03/21/24
$GPCR there it is>..BREAKOUT!
Student_
Posted - 03/21/24
$GPCR I don’t understand why Structure is up, given the data was lackluster. I realize it’s a big market, but what niche will this have as an inferior product to Lilly or now, possibly NVO’s oral.
Axadude
Posted - 03/20/24
$GPCR $VKTX Neither have that money ain’t happening
NoFearHere
Posted - 03/20/24
$GPCR this stock is another room that sleeps even when it's rising it's unknown I suppose I can't couldn't have blocked everybody in here🤣🤣🤣
NoFearHere
Posted - 03/20/24
$GPCR that macd's just now curling up there's inside or buys going on after hours it's Prime to break out above that $48 and run into the 50s watching closely for a swing trade opportunity
NoFearHere
Posted - 03/20/24
$GPCR above $43 which clears the 50 and 200 dma this thing has a clear sky to 48 dollars along with what's going on with these form Four A's filed after hours it could have a run
NoFearHere
Posted - 03/20/24
$GPCR a lot of fours being filed after hours that's a bullish sign
BTECHINV
Posted - 03/20/24
Per today's BMO Summit, projected future GLP-1 TAM estimates rising well north of $100 B+, global map from today's Economist newsletter (picture worth a thousand words). The medical aspects of Obesity are coming into focus in potential Gen-3 drugs, playing to Pemvidutide's unique strengths as a single drug candidate that cuts across the four major domains of Liver Fat, Cardiometabolic, Obesity (WL sustainability) and safety. Best wishes to all, future is bright for emerging leaders (imo): $ALT, $VKTX, $MDGL, $GPCR Disclosure: Long Altimmune (Pemvidutide, GCGR/GLP-1), not medical advice, not investment advice.
Crackjack
Posted - 03/20/24
$GPCR $VKTX shhhh. Steve, we had decided not to disclose in public forums…
bioanticipation
Posted - 03/20/24
$VKTX don’t shoot the messenger but wisdom tells me that Viking probably announces a buyout tomorrow at $140. $13.5B all cash probably Merck or Pfizer. The option chain doesn’t run the way it has on a data play. It has buyout written all over it. In fact based on all available evidence there is no way the oral has a home run enough to catapult this as much as the options suggesting. $gpcr running after hours too as that’s a good proxy way to play Viking buyout. (I know Cnbc mention but it wasn’t anything that should lead to a 10% move)